Related Experiment Video
Updated: Jun 29, 2025

12:59
Barnes Maze Testing Strategies with Small and Large Rodent Models
Published on: February 26, 2014
41.9K
Augmented Mitochondrial Transfer Involved in Astrocytic PSPH Attenuates Cognitive Dysfunction in db/db Mice
Hongli Ma1,2, Shuxuan He1, Yansong Li1
1Department of Anesthesiology & Center for Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Molecular Neurobiology
|April 4, 2024
Summary
Astrocytic phosphoserine phosphatase (PSPH) alleviates diabetes-associated cognitive dysfunction (DACD) by enhancing mitochondrial transfer to neurons. Upregulating PSPH in astrocytes offers a potential therapeutic strategy for DACD.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Cell Biology
Background:
- Diabetes-associated cognitive dysfunction (DACD) is a significant cause of mortality in diabetic patients.
- Phosphoserine phosphatase (PSPH) is key in L-serine biosynthesis and insulin signaling.
- CD38 mediates mitochondrial transfer and is activated by the insulin pathway.
Purpose of the Study:
- To investigate if astrocytic PSPH improves DACD by promoting mitochondrial transfer to neurons.
- To elucidate the mechanism by which astrocytic PSPH influences DACD.
Main Methods:
- Overexpression of PSPH in astrocytes of db/db mice.
- Morris Water Maze (MWM) test for cognitive function assessment.
- In vivo and in vitro analysis of spine density.
- Investigation of the insulin signaling pathway and CD38 expression.
Main Results:
- Overexpression of astrocytic PSPH alleviated DACD in db/db mice.
- PSPH stimulation increased astrocyte-derived mitochondrial transfer into neurons.
- Astrocytic PSPH amplified CD38 expression via the insulin pathway, promoting mitochondrial transfer.
- Increased spine density was observed both in vivo and in vitro.
Conclusions:
- Astrocytic PSPH plays a crucial role in alleviating DACD.
- The mechanism involves PSPH-mediated insulin pathway activation, leading to CD38 upregulation and enhanced astrocytic mitochondrial transfer.
- Targeting astrocytic PSPH presents a promising therapeutic approach for DACD.

